Have any questions about how to use the community? Check out the Help Discussion.

APOE Test not covered by Medicare?

Our neurologist ordered an APOE blood test prior to prescribing Kisunla. When we went for the test we were told it would not be covered by Medicare or Tricare and would cost $700. Is this what others have experienced?

And is the APOE test actually required? We've done the PET scan. Of course, we'll find the money if the APOE test is essential in minimizing risk. Just curious what others experience has been.

Comments

  • harshedbuzz
    harshedbuzz Member Posts: 6,005
    Eighth Anniversary 1,500 Insightfuls Reactions 1,500 Likes 5000 Comments
    Member

    I believe the APOE testing is standard for safety reasons.

  • SDianeL
    SDianeL Member Posts: 2,618
    2500 Comments 1,000 Care Reactions 1,000 Likes 500 Insightfuls Reactions
    Member

    found this online: Yes, 

    Medicare Part B covers the APOE gene testwhen it is ordered by a treating physician to help determine a patient's eligibility and risk for specific FDA-approved amyloid-lowering infusion therapies for early Alzheimer's disease, such as Leqembi (lecanemab). 

  • SDianeL
    SDianeL Member Posts: 2,618
    2500 Comments 1,000 Care Reactions 1,000 Likes 500 Insightfuls Reactions
    Member

    and this:

    1. Consult with your doctor: Have your doctor determine if the ApoE test is medically necessary for your specific condition.
    2. Contact TRICARE: Before the test, contact your TRICARE contractor to confirm coverage based on your specific situation. You can also ask about pre-authorization requirements. 
  • SDianeL
    SDianeL Member Posts: 2,618
    2500 Comments 1,000 Care Reactions 1,000 Likes 500 Insightfuls Reactions
    Member
    edited November 16

    I believe the test is medically necessary before infusion to determine possible side effects like brain swelling or brain bleeding. The purpose of an APOE test before an infusion is 

    to assess the risk of a serious side effect called Amyloid-Related Imaging Abnormalities (ARIA)(also known as brain swelling or microbleeds) when starting certain Alzheimer's disease treatments

    , like lecanemab. Testing identifies if a patient carries the APOE ε4 allele, as 

    APOE ε4 homozygotes have a much higher risk of developing ARIA

     compared to heterozygotes and noncarriers. This information helps guide the decision to proceed with treatment and informs the discussion about risks versus benefits with the patient. 

  • harshedbuzz
    harshedbuzz Member Posts: 6,005
    Eighth Anniversary 1,500 Insightfuls Reactions 1,500 Likes 5000 Comments
    Member

    @HutchGS

    I wonder if the ordering physician improperly or incompletely coded the order? That's a common scenario for insurance denials.

Commonly Used Abbreviations


DH = Dear Husband
DW= Dear Wife, Darling Wife
LO = Loved One
ES = Early Stage
EO = Early Onset
FTD = Frontotemporal Dementia
VD = Vascular Dementia
MC = Memory Care
AL = Assisted Living
POA = Power of Attorney
Read more